Jan Tavernier Lab

Research focus

The a-helical bundle cytokine family comprises most interleukins, the interferons and colony stimulating factors, together with hormones such as growth hormone and leptin. They control many levels of intercellular communication involved in development, host defense and metabolism in higher eukaryotes. Several human diseases are associated with malfunctioning of this communication system. Their receptors are composed of an extracellular, ligand-binding part that is linked to the cytosolic, signaling domain by a single transmembrane region. We are investigating several key aspects of these receptors. Detailed studies are ongoing to understand the molecular mechanisms that underlie receptor activation upon ligand binding. We focus here on the leptin receptor, and from these insights several leptin antagonists were developed. A key signaling event downstream of these receptors is activation of the JAK/STAT pathway, and our MAPPIT two-hybrid toolbox is based on this signaling route. Using MAPPIT and other technologies including molecular modeling, we investigate several protein interactions that are important in the innate immune response.


Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination TreatmentsCauwels A* Van Lint S* Paul F Garcin G De Koker S Van Parys A Wueest T Gerlo S Van Der Heyden J Bordat Y Catteeuw D Rogge E Verhee A Vandekerckhove B Kley N Uzé G* Tavernier J*CANCER RESEARCH, 78, 463-474, 2018* or °: authors contributed equally
Proteome-scale Binary Interactomics in Human CellsLievens Samuel Van Der Heyden José Masschaele Delphine De Ceuninck Leentje Petta Ioanna Gupta Surya De Puysseleyr Veronic Vauthier Virginie Lemmens Irma De Clercq D. J Defever Dieter Vanderroost Nele De Smet Anne-Sophie Eyckerman Sven Van Calenbergh S. Martens Lennart De Bosscher Karolien Libert Claude Hill D Vidal M. Tavernier JanMOLECULAR & CELLULAR PROTEOMICS, 15, 3624-3639, 2016
A proteome-scale map of the human interactome networkRolland T Ta an M Charloteaux B Pevzner S. J Zhong Q Sahni N Yi S Lemmens Irma Fontanillo C Mosca R Kamburov A Ghiassian S. D Yang X. Ghamsari L Balcha D Begg B. E Braun P. Brehme M Broly M Carvunis A. R. Convery-Zupan D Corominas R Coulombe-Huntington J Dann E. Dreze M. Dricot A. Fan C. Franzosa E Gebreab F. Gutierrez B. J Hardy M. F Jin M Kang S Kiros R Lin G. N Luck K Macwilliams A Menche J Murray R. R. Palagi A Poulin M. M Rambout X Rasla J Reichert P Romero V Ruyssinck Elien Sahalie J. Scholz A Shah A. M Sharma A Shen Y Spirohn K Tam S. Tejeda A. O Trigg S. A Twizere J. C Vega K Walsh J Cusick M. E. Xia Y Barabasi A. L. Iakoucheva L. M. Aloy P De Las Rivas J Tavernier Jan Calderwood M. A Hill D Hao T. Roth F. P. Vidal M.CELL, 159, 1212-26, 2014
High efficiency cell-specific targeting of cytokine activityGarcin G Paul F Staufenbiel M Bordat Y Van Der Heyden J Wilmes S Cartron G Apparailly F De Koker S Piehler J* Tavernier J* Uzé G*Nature Communications, 5, 3016, 2014* or °: authors contributed equally
The Sin3a repressor complex is a master regulator of STAT transcriptional activityIcardi Laura Mori Raffaele Gesellchen Viola Eyckerman Sven De Cauwer Lode Verhelst Judith Vercauteren K Saelens Xavier Meuleman P Leroux-Roels G De Bosscher Karolien Boutros M Tavernier JanPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 109, 12058-63, 2012

Job openings


Jan Tavernier (VIB-UGent) in Top 20 Translational Researchers

12/12/2019 - Jan Tavernier (VIB-UGent Center for Medical Biotechnology) is only the second Belgian ever to make it onto the US-dominated list. The list is an aggregate score of number of patents granted in that year, patent citations and h-index.

Interesting news from VIB Medical Biotechnology Center UGent

29/07/2016 - The labs of Jan Tavernier, Kris Gevaert and Sven Eyckerman from the VIB Medical Biotechnology Center, UGent tackle some of the most fundamental life sciences questions in their research into the detection and analysis of protein-protein interaction.

Jan Tavernier

Jan Tavernier

Research area(s)


​PhD: Ghent University, Belgium, 1984
VIB Group leader since 1996
Acting department director 2010-2015

Contact Info

VIB-UGent Center for Medical BiotechnologyAlbert Baertsoenkaai 3 9000 GENTRoute description